Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Delayed hemolytic transfusion reaction in sickle cell disease.

Literature DB >> 20051821

Delayed hemolytic transfusion reaction in sickle cell disease.

Abstract

Delayed hemolytic transfusion reactions are potentially life-threatening complications observed in patients with sickle cell disease. We review the clinical features, pathophysiology, laboratory evaluation, and management of this complication. It is important that delayed hemolytic transfusion reactions be included in the differential diagnosis of acute pain episodes following a red blood cell transfusion in a patient with sickle cell disease.

Entities: Chemical Disease Gene Species

Mesh：

Year: 2010 PMID： 20051821 PMCID： PMC2837790 DOI： 10.1097/MAJ.0b013e3181c70e14

Source DB: PubMed Journal: Am J Med Sci ISSN： 0002-9629 Impact factor: 2.378

29 in total

1. Hyperhemolytic transfusion reaction in sickle cell disease.

Authors: N Win; H Doughty; P Telfer; B J Wild; T C Pearson
Journal: Transfusion Date: 2001-03 Impact factor: 3.157

Review 2. Mechanisms of suicidal erythrocyte death.

Authors: Karl S Lang; Philipp A Lang; Christian Bauer; Christophe Duranton; Thomas Wieder; Stephan M Huber; Florian Lang
Journal: Cell Physiol Biochem Date: 2005

3. Fatal delayed transfusion reaction in a sickle cell anemia patient with Serratia marcescens sepsis.

Authors: Desiree Seeyave; Ninad Desai; Scott Miller; Sreedhar P Rao; Steve Piecuch
Journal: J Natl Med Assoc Date: 2006-10 Impact factor: 1.798

Review 4. Transfusion management of sickle cell disease.

Authors: A S Wayne; S V Kevy; D G Nathan
Journal: Blood Date: 1993-03-01 Impact factor: 22.113

Review 5. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Authors: Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal: Blood Rev Date: 2006-11-07 Impact factor: 8.250

6. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

Authors: E P Vichinsky; L D Neumayr; A N Earles; R Williams; E T Lennette; D Dean; B Nickerson; E Orringer; V McKie; R Bellevue; C Daeschner; E A Manci
Journal: N Engl J Med Date: 2000-06-22 Impact factor: 91.245

Review 7. Treating anemia.

Authors: K E King; P M Ness
Journal: Hematol Oncol Clin North Am Date: 1996-12 Impact factor: 3.722

8. Broadening the base of a rare donor program by targeting minority populations.

Authors: K M Beattie; A W Shafer
Journal: Transfusion Date: 1986 Sep-Oct Impact factor: 3.157

9. Delayed hemolytic transfusion reaction presenting as sickle-cell crisis.

Authors: W J Diamond; F L Brown; P Bitterman; H G Klein; R J Davey; R M Winslow
Journal: Ann Intern Med Date: 1980-08 Impact factor: 25.391

10. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.

Authors: Philippe Chadebech; Anoosha Habibi; Ruben Nzouakou; Dora Bachir; Natacha Meunier-Costes; Philippe Bonin; Martine Rodet; Btissam Chami; Frederic Galacteros; Philippe Bierling; France Noizat-Pirenne
Journal: Transfusion Date: 2009-04-28 Impact factor: 3.157

21 in total

1. [Hemoglobin disorders].

Authors: R Dickerhoff
Journal: Internist (Berl) Date: 2015-09 Impact factor: 0.743

2. Interventions for chronic kidney disease in people with sickle cell disease.

Authors: Noemi Ba Roy; Patricia M Fortin; Katherine R Bull; Carolyn Doree; Marialena Trivella; Sally Hopewell; Lise J Estcourt
Journal: Cochrane Database Syst Rev Date: 2016-10

3. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors: Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal: Cochrane Database Syst Rev Date: 2016-10

Review 4. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors: Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal: Cochrane Database Syst Rev Date: 2017-05-13

5. Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype.

Authors: Monique Silvy; Christophe Tournamille; Jérôme Babinet; Sadaf Pakdaman; Sylvain Cohen; Jacques Chiaroni; Frédéric Galactéros; Philippe Bierling; Pascal Bailly; France Noizat-Pirenne
Journal: Haematologica Date: 2014-04-11 Impact factor: 9.941

10. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.

Authors: Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella
Journal: Cochrane Database Syst Rev Date: 2016-02-08